Co-culture supernatant containing autologous CIK cells and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 广州市金航生物科技有限公司
- Publication Date
- 2018-03-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the biological field, in particular to a co-culture supernatant containing autologous CIK cells and application thereof. Background technique
[0002] Advances in immune cell biology and immune molecular biology have advanced the application of immunology in tumor therapy. Nowadays, tumor immunotherapy has become one of the basic means of tumor treatment, among which cell-mediated adoptive immunotherapy is one of the current research hotspots. By infusing specific or non-specific immune effector cells that can inhibit the growth of tumor cells into tumor patients, it can directly kill tumor cells, or induce the body's immune response in patients to achieve the purpose of inhibiting and treating tumors. The current research and clinical preliminary data on tumor immune effector cells suggest that cytokine-induced killer (autologous CIK) cells are a new type of highly efficient MHC non-restricted immune effector with broad-spect...